Technical Analysis for SKYE - Skye Bioscience Inc

Grade Last Price % Change Price Change
A 4.1400 18.29% 0.6400
SKYE closed down 17.06 percent on Friday, December 8, 2023, on 3.56 times normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
4 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up

Date Alert Name Type % Chg
Bearish Engulfing Bearish 18.29%
Slingshot Bullish Bullish Swing Setup 18.29%
Volume Surge Other 18.29%
Wide Range Bar Range Expansion 18.29%
Upper Bollinger Band Walk Strength 18.29%
Wide Bands Range Expansion 18.29%
Overbought Stochastic Strength 18.29%
Upper Bollinger Band Touch Strength 18.29%
New 52 Week Closing High Bullish -1.90%
New Uptrend Bullish -1.90%

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Rose Above Upper Bollinger Band about 1 hour ago
Slingshot Bullish Entry about 1 hour ago
Rose Above Previous Day's High about 1 hour ago
Gap Up Partially Closed about 1 hour ago
Up 2 ATRs about 1 hour ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Skye Bioscience Inc Description

Skye Bioscience, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of cannabinoid-based therapeutics for unmet medical needs worldwide. The company's lead product candidate is NB1111, which is in preclinical trials for the treatment of glaucoma. It is also developing NB2222, a product candidate in preclinical trials for use in the treatment of various eye diseases, including uveitis, dry eye syndrome, macular degeneration, and diabetic retinopathy; and NB3111, a cannabinoid cocktail in testing for use as an anti-infective agent against various strains of antibiotic resistant bacteria, including methicillin-resistant Staphylococcus aureus. The company was formerly known as Emerald Bioscience, Inc. and changed its name to Skye Bioscience, Inc. in January 2021. Skye Bioscience, Inc. was founded in 2012 and is based in San Diego, California


Sector: Healthcare
Industry: Biotechnology
Keywords: Medical Specialties Biopharmaceutical Clinical Medicine Diabetes Ophthalmology Diabetic Retinopathy Glaucoma Macular Degeneration Retinopathy Uveitis Eye Disease Staphylococcus Aureus Blindness Dry Eye Syndrome Eye Diseases Treatment Of Glaucoma

Is SKYE a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 4.45
52 Week Low 0.0074
Average Volume 7,620
200-Day Moving Average 0.7056
50-Day Moving Average 2.2588
20-Day Moving Average 2.0222
10-Day Moving Average 2.4392
Average True Range 0.4671
RSI (14) 68.45
ADX 25.34
+DI 40.0538
-DI 22.8047
Chandelier Exit (Long, 3 ATRs) 3.0487
Chandelier Exit (Short, 3 ATRs) 2.8413
Upper Bollinger Bands 3.7191
Lower Bollinger Band 0.3253
Percent B (%b) 0.94
BandWidth 167.8271
MACD Line 0.3977
MACD Signal Line 0.1129
MACD Histogram 0.2848
Fundamentals Value
Market Cap 875.26 Million
Num Shares 250 Million
EPS 0.03
Price-to-Earnings (P/E) Ratio 140.00
Price-to-Sales 0.00
Price-to-Book 5.33
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.6000
Resistance 3 (R3) 5.6667 5.0333 5.2500
Resistance 2 (R2) 5.0333 4.4985 5.0000 5.1332
Resistance 1 (R1) 4.2667 4.1681 3.9500 4.2000 5.0166
Pivot Point 3.6333 3.6333 3.4750 3.6000 3.6333
Support 1 (S1) 2.8667 3.0985 2.5500 2.8000 1.9834
Support 2 (S2) 2.2333 2.7681 2.2000 1.8668
Support 3 (S3) 1.4667 2.2333 1.7500
Support 4 (S4) 1.4000